GPT and non-small cell lung carcinoma: At the time of the initial diagnosis of non-small cell lung cancer (NSCLC), the patient’s liver biochemistry (including ALT, AST, ALP, and bilirubin) and imaging studies (ultrasound and CT scan) were within normal limits, indicating no evidence of pre-existing liver disease.